Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
19.68
+0.09 (0.46%)
Nov 17, 2026, 3:00 PM CST

SHA:600332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,90314,94018,27321,30922,50022,377
Short-Term Investments
-8,8614,446729.162,117-
Trading Asset Securities
-4-456.87-
Cash & Short-Term Investments
11,90323,80522,71922,04224,67322,377
Cash Growth
-35.07%4.78%3.07%-10.66%10.26%14.61%
Accounts Receivable
23,52520,94019,45619,59819,16817,211
Other Receivables
1,4501,186993.65882.35920.511,276
Receivables
24,97622,12620,44920,48020,08818,486
Inventory
12,20613,13812,81211,50710,67210,438
Other Current Assets
12,9002,4491,7821,9551,6311,510
Total Current Assets
61,98461,51857,76255,98457,06452,811
Property, Plant & Equipment
8,5598,3657,9397,5166,5705,684
Long-Term Investments
10,7178,79310,1469,4525,8972,891
Goodwill
919.94834.09830.85829.47829.47829.47
Other Intangible Assets
3,1783,1812,8292,8862,5852,582
Long-Term Deferred Tax Assets
1,2961,2861,2101,164865.34794.23
Long-Term Deferred Charges
4.94162.47558.49499.77407.47143.05
Other Long-Term Assets
560.95370.9407.77256.22446.54382.46
Total Assets
87,21984,51181,68478,58774,66566,118

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
17,25417,57116,32015,68614,96114,733
Accrued Expenses
837.883,5693,6733,6513,4843,478
Short-Term Debt
11,7289,8609,1237,7999,1468,428
Current Portion of Long-Term Debt
1,1342,0271,33236.45498.5830.03
Current Portion of Leases
-185.2190.57213.38208.15215.77
Current Income Taxes Payable
483.98170.9118.4249.26237143.41
Current Unearned Revenue
745.422,8335,0725,4305,6442,740
Other Current Liabilities
5,5812,9093,0883,1703,2162,485
Total Current Liabilities
37,76439,12538,91636,23537,39532,254
Long-Term Debt
5,8153,1742,8063,3241,639752.81
Long-Term Leases
374.62371.47445.72578.19545.84497.7
Long-Term Unearned Revenue
1,0721,0421,0021,001930.93826.86
Pension & Post-Retirement Benefits
0.280.290.30.290.320.3
Long-Term Deferred Tax Liabilities
587.88599.37625.56639.53394.59331.73
Other Long-Term Liabilities
204.7116.74119.31130.6121.45127.87
Total Liabilities
45,81944,42843,91441,90941,02734,791

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,6261,6261,6261,6261,6261,626
Additional Paid-In Capital
10,32410,32410,11410,10610,1069,957
Retained Earnings
27,13425,86124,17923,21220,34717,497
Comprehensive Income & Other
-47.78-22.6-13.84-24.34-12.9-17.48
Total Common Equity
39,03537,78835,90534,91932,06529,062
Minority Interest
2,3652,2951,8651,7591,5732,264
Shareholders' Equity
41,40040,08337,77036,67833,63831,327
Total Liabilities & Equity
87,21984,51181,68478,58774,66566,118

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
19,05215,61713,89711,95112,0389,924
Net Cash (Debt)
-7,1498,1888,82310,09112,63512,453
Net Cash Growth
--7.20%-12.57%-20.14%1.47%24.99%
Net Cash Per Share
-4.405.045.436.217.777.66
Filing Date Shares Outstanding
1,6261,6261,6261,6261,6261,626
Total Common Shares Outstanding
1,6261,6261,6261,6261,6261,626
Working Capital
24,22022,39418,84719,74819,66920,557
Book Value Per Share
24.0123.2422.0821.4819.7217.88
Tangible Book Value
34,93833,77332,24531,20328,65125,650
Tangible Book Value Per Share
21.4920.7719.8319.1917.6215.78
Buildings
-6,4645,2134,3283,6303,317
Machinery
-5,5215,1064,4164,0253,582
Construction In Progress
-1,1501,8462,4052,1081,564